These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 36346100)

  • 81. Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy.
    Sun A; Durocher-Allen LD; Ellis PM; Ung YC; Goffin JR; Ramchandar K; Darling G
    Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):658-666. PubMed ID: 30007803
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The impact of angiogenesis inhibitors on survival of patients with small cell lung cancer.
    Shi X; Dong X; Young S; Chen AM; Liu X; Zheng Z; Huang K; Lu D; Feng S; Morahan G; Cai K
    Cancer Med; 2019 Oct; 8(13):5930-5938. PubMed ID: 31433125
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Immunotherapy in Lung Cancer: Current Landscape and Future Directions.
    Mamdani H; Matosevic S; Khalid AB; Durm G; Jalal SI
    Front Immunol; 2022; 13():823618. PubMed ID: 35222404
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects.
    Demedts IK; Vermaelen KY; van Meerbeeck JP
    Eur Respir J; 2010 Jan; 35(1):202-15. PubMed ID: 20044461
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLC.
    Thomas PL; Groves SM; Zhang YK; Li J; Gonzalez-Ericsson P; Sivagnanam S; Betts CB; Chen HC; Liu Q; Lowe C; Chen H; Boyd KL; Kopparapu PR; Yan Y; Coussens LM; Quaranta V; Tyson DR; Iams W; Lovly CM
    J Thorac Oncol; 2021 Jul; 16(7):1211-1223. PubMed ID: 33839362
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Therapeutic efficacy analysis of immunotherapy in small cell lung cancer].
    Zhong J; Zheng QW; Zhao J; Wang ZP; Wu MN; Zhuo ML; Wang YY; Li JJ; Yang X; Chen HX; An TT
    Zhonghua Zhong Liu Za Zhi; 2020 Sep; 42(9):771-776. PubMed ID: 32988161
    [No Abstract]   [Full Text] [Related]  

  • 87. Talazoparib Dual-targeting on Poly (ADP-ribose) Polymerase-1 and -16 Enzymes Offers a Promising Therapeutic Strategy in Small Cell Lung Cancer Therapy: Insight from Biophysical Computations.
    Mgoboza C; Okunlola FO; Akawa OB; Aljoundi A; Soliman MES
    Cell Biochem Biophys; 2022 Sep; 80(3):495-504. PubMed ID: 35588345
    [TBL] [Abstract][Full Text] [Related]  

  • 88. What's new in small cell lung cancer - extensive disease? An overview on advances of systemic treatment in 2016.
    Seeber A; Leitner C; Philipp-Abbrederis K; Spizzo G; Kocher F
    Future Oncol; 2017 Jul; 13(16):1427-1435. PubMed ID: 28685608
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A novel mutation panel for predicting etoposide resistance in small-cell lung cancer.
    Qiu Z; Lin A; Li K; Lin W; Wang Q; Wei T; Zhu W; Luo P; Zhang J
    Drug Des Devel Ther; 2019; 13():2021-2041. PubMed ID: 31417239
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Is there a Place for Bevacizumab in Patients with Extensive-Stage Small Cell Lung Cancer?
    Roviello G; Generali D
    Curr Cancer Drug Targets; 2016; 16(3):209-14. PubMed ID: 26548757
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer.
    Ricciuti B; Kravets S; Dahlberg SE; Umeton R; Albayrak A; Subegdjo SJ; Johnson BE; Nishino M; Sholl LM; Awad MM
    J Immunother Cancer; 2019 Mar; 7(1):87. PubMed ID: 30922388
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Ganitumab for the treatment of small-cell lung cancer.
    Martínez P; Sales Fidalgo PA; Felip E
    Expert Opin Investig Drugs; 2014 Oct; 23(10):1423-32. PubMed ID: 25189625
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC.
    Niu X; Chen L; Li Y; Hu Z; He F
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):273-285. PubMed ID: 35288298
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Second-line therapy of squamous non-small cell lung cancer: an evolving landscape.
    Lazzari C; Karachaliou N; Gregorc V; Bulotta A; Gonzalez-Cao M; Verlicchi A; Altavilla G; Rosell R; Santarpia M
    Expert Rev Respir Med; 2017 Jun; 11(6):469-479. PubMed ID: 28467720
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The efficiency and safety of immune checkpoint inhibitors in the treatment of small cell lung cancer: a meta-analysis.
    Zhang S; Bi M
    Ann Palliat Med; 2020 Nov; 9(6):4081-4088. PubMed ID: 33302668
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer.
    Zhou F; Zhao W; Gong X; Ren S; Su C; Jiang T; Zhou C
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32900864
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.].
    Minuti G; Stefani A; Carpano S; D'Argento E; Giusti R; Martelli O; Metro G; Gelibter AJ; Antonini Cappellini GC; Carta A; Fadda GM; Nelli F; Ricciardi S; Russano M; Bria E; Cappuzzo F
    Recenti Prog Med; 2021 Oct; 112(10):639-646. PubMed ID: 34647533
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Immunotherapy Advances in Small Cell Lung Cancer].
    Xu Y; Zhan P; Song Y
    Zhongguo Fei Ai Za Zhi; 2020 Nov; 23(11):989-998. PubMed ID: 32752583
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Atezolizumab plus carboplatin and etoposide in small cell lung cancer patients previously treated with platinum-based chemotherapy.
    Ishii H; Azuma K; Kawahara A; Matsuo N; Tokito T; Hoshino T
    Invest New Drugs; 2021 Feb; 39(1):269-271. PubMed ID: 32783090
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Complete response to pembrolizumab in a patient with extensive-stage small-cell lung cancer: a case report.
    Zhang N; Zhu J; Lv H
    Ann Palliat Med; 2020 Jul; 9(4):2347-2352. PubMed ID: 32762231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.